Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)

• Company Description    GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. Number of Employees: 697

• Price / Volume Information    Yesterday's Closing Price: $3.39 Daily Weekly Monthly 20 Day Moving Average: 1,101,309 shares Shares Outstanding: 342.57 (millions) Market Capitalization: $1,161.33 (millions) Beta: 1.59 52 Week High: $5.81 52 Week Low: $1.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.45% -2.87% 12 Week 18.95% 13.98% Year To Date 25.09% 10.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 OLYMPIC BOULEVARD - SANTA MONICA,CA 90404 USA ph: 855-268-2822 fax: - ir@goodrx.com http://www.goodrx.com

• General Corporate Information    Officers Wendy Barnes - Chief Executive Officer and President Trevor Bezdek - Chairman Christopher McGinnis - Chief Financial Officer Romin Nabiey - Chief Accounting Officer Christopher Adams - Director Peer Information GoodRx Holdings, Inc. (CHCR) GoodRx Holdings, Inc. (ESRX) GoodRx Holdings, Inc. (MYDP) GoodRx Holdings, Inc. (COR) GoodRx Holdings, Inc. (GBCS) GoodRx Holdings, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 38246G108 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/03/26 Share - Related Items Shares Outstanding: 342.57 Most Recent Split Date: (:1) Beta: 1.59 Market Capitalization: $1,161.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.16 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 12.96% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/03/26

• Fundamental Ratios P/E Current FY Estimate: 21.87 Trailing 12 Months: 22.60 PEG Ratio: 1.69 Price Ratios Price/Book: 1.79 Price/Cash Flow: 8.47 Price / Sales: 1.48 EPS Growth vs. Year Ago Period: -20.00% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: -1.31% vs. Previous Quarter: 3.30% ROE 06/30/26 - 7.22 03/31/26 - 7.90 12/31/25 - 9.31 ROA 06/30/26 - 2.53 03/31/26 - 3.23 12/31/25 - 4.38 Current Ratio 06/30/26 - 1.38 03/31/26 - 1.47 12/31/25 - 2.61 Quick Ratio 06/30/26 - 1.38 03/31/26 - 1.47 12/31/25 - 2.61 Operating Margin 06/30/26 - 5.72 03/31/26 - 6.22 12/31/25 - 7.35 Net Margin 06/30/26 - 2.07 03/31/26 - 2.61 12/31/25 - 3.82 Pre-Tax Margin 06/30/26 - 5.27 03/31/26 - 5.78 12/31/25 - 7.10 Book Value 06/30/26 - 1.89 03/31/26 - 1.82 12/31/25 - 1.81 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - 0.74 03/31/26 - 0.78 12/31/25 - 0.78 Debt-to-Capital 06/30/26 - 42.65 03/31/26 - 43.68 12/31/25 - 43.95

Powered by Zacks Investment Research ©